EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endothelial-to-Mesenchymal Transition in Health and Disease: Molecular Insights and Therapeutic Implications

Ran Kim, Woochul Chang iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311724 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ran Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology Education, College of Education, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Endothelial Cells. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science & ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial-to-mesenchymal transition (EndMT) is a cellular program implicated in fibrosis, vascular remodeling, and the tumor microenvironment across multiple organs. We synthesize mechanistic pathways including TGF-β/SMAD, non-canonical (MAPK, PI3K/AKT, Rho/ROCK), Notch, and Wnt/β-catenin cascades. Their crosstalk with hypoxia, inflammatory cues, and epigenetic mechanisms can drive loss of endothelial identity and acquisition of mesenchymal characteristics. We outline disease contexts in the heart, lungs, kidneys, liver, central nervous system, and cancer, highlighting context-dependent contributory roles of EndMT. Therapeutically, we review pathway-targeted agents, epigenetic inhibitors, microRNA-based strategies, antibodies/biologics, small molecules and natural compounds, and cell- and gene-based interventions. Finally, we outline a translational roadmap that pairs patient-derived iPSC/organoid and organ-on-a-chip platforms to stratify EndMT states and prioritize targets. We also explore combination regimens that integrate multi-pathway modulation with epigenetic and immune approaches, aiming to deliver clinically meaningful anti-fibrotic benefits while better preserving physiological signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionEndothelial CellsHumansAnimalsSignal TransductionEpigenesis, GeneticNeoplasmsFibrosis

Stichwörter der Autor:innen

TGF-β/SMAD signalingendothelial dysfunctionendothelial-to-mesenchymal transitiontranslational therapeuticsvascular remodeling

Autor:innen und Institutionen

  • Department of Biology Education, College of Education, Pusan National University, Busan 46241, Republic of Korea.
  • Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50611, Republic of Korea.

ORCID-Profile: Woochul Chang

Förderung

  • National Research Foundation of Korea
  • Ministry of Science & ICT

Zitieren

APA

Kim, R., & Chang, W. (2025). Endothelial-to-Mesenchymal Transition in Health and Disease: Molecular Insights and Therapeutic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311724

Vancouver

Kim R, Chang W. Endothelial-to-Mesenchymal Transition in Health and Disease: Molecular Insights and Therapeutic Implications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311724

BibTeX
@article{Kim2025,
  author = {Kim, Ran and Chang, Woochul},
  title = {Endothelial-to-Mesenchymal Transition in Health and Disease: Molecular Insights and Therapeutic Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311724}
}
Kostenlos starten →